I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Desai, Sajjad
38
results:
Search for persons
X
Format
Online (38)
Mediatypes
Articles (Online) (12)
Bookchapter (Online) (1)
OpenAccess-fulltext (25)
Sorted by: Relevance
Sorted by: Year
?
1
Post-marketing safety surveillance of the rotavirus vaccine..:
Kang, Gagandeep
;
Lakhkar, Anand
;
Bhamare, Chetanraj
...
Vaccine: X. 15 (2023) - p. 100362 , 2023
Link:
https://doi.org/10.1016/..
?
2
A phase I clinical study to assess safety and immunogenicit..:
Desai, Sajjad
;
Anil, K.
;
Potey, Anirudha Vyankatesh
...
npj Vaccines. 7 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
3
Response to: Letter from P. Gillard and B. Benninghoff:
Rathi, Niraj
;
Desai, Sajjad
;
Kawade, Anand
...
Vaccine. 37 (2019) 23 - p. 2991-2992 , 2019
Link:
https://doi.org/10.1016/..
?
4
Non-interference of Bovine-Human reassortant pentavalent ro..:
Desai, Sajjad
;
Rathi, Niraj
;
Kawade, Anand
...
Vaccine. 36 (2018) 37 - p. 5519-5523 , 2018
Link:
https://doi.org/10.1016/..
?
5
A Phase III open-label, randomized, active controlled clini..:
Rathi, Niraj
;
Desai, Sajjad
;
Kawade, Anand
...
Vaccine. 36 (2018) 52 - p. 7943-7949 , 2018
Link:
https://doi.org/10.1016/..
?
6
Safety and tolerability of a liquid bovine rotavirus pentav..:
Anil, K.
;
Desai, Sajjad
;
Bhamare, Chetanraj
...
Vaccine. 36 (2018) 12 - p. 1542-1544 , 2018
Link:
https://doi.org/10.1016/..
?
7
A randomized Phase III clinical trial to assess the efficac..:
Kulkarni, Prasad S.
;
Desai, Sajjad
;
Tewari, Tushar
...
Vaccine. 35 (2017) 45 - p. 6228-6237 , 2017
Link:
https://doi.org/10.1016/..
?
8
Bovine rotavirus pentavalent vaccine development in India:
Zade, Jagdish K.
;
Kulkarni, Prasad S.
;
Desai, Sajjad A.
...
Vaccine. 32 (2014) - p. A124-A128 , 2014
Link:
https://doi.org/10.1016/..
?
9
Post-marketing safety surveillance of the rotavirus vaccine..:
Kang, Gagandeep
;
Lakhkar, Anand
;
Bhamare, Chetanraj
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430202/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
A phase I clinical study to assess safety and immunogenicit..:
Desai, Sajjad
;
Anil, K
;
Potey, Anirudha Vyankatesh
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763341/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Non-interference of Bovine-Human reassortant pentavalent ro..:
Desai, Sajjad
;
Rathi, Niraj
;
Kawade, Anand
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143481/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
12
A Phase III open-label, randomized, active controlled clini..:
Rathi, Niraj
;
Desai, Sajjad
;
Kawade, Anand
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288065/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
13
A randomized Phase III clinical trial to assess the efficac..:
Kulkarni, Prasad S
;
Desai, Sajjad
;
Tewari, Tushar
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651219/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
14
Post-marketing safety surveillance of the rotavirus vaccine..:
Gagandeep Kang
;
Anand Lakhkar
;
Chetanraj Bhamare
...
http://www.sciencedirect.com/science/article/pii/S2590136223001031. , 2023
Link:
https://doi.org/10.1016/..
?
15
A phase I clinical study to assess safety and immunogenicit..:
Sajjad Desai
;
K. Anil
;
Anirudha Vyankatesh Potey
...
https://doi.org/10.1038/s41541-022-00595-6. , 2022
Link:
https://doi.org/10.1038/..
1-15
